The Filings Report

Axon Enterprise

AXONNasdaqCIK 1069183Industrials / Aerospace & Defensefiscal year ends December65 quarters since 2010

Revenue, Q2 FY2026
$904M
+35.3% on Q2 FY2025
Net income
$29M
−18.5% on Q2 FY2025
Free cash flow
−$972K
+99.2% on Q2 FY2025
Diluted EPS
$0.36
−18.2% on Q2 FY2025
Revenue, TTM
$3.2B
trailing four quarters
Net margin, TTM
6.2%
net income $199M
Free cash flow, TTM
$133M
$266M less $133M capex
Cash and equivalents
$598M
long-term debt $1.7B, Jun 30, 2026
Shares, 12-month change
+3.5%
81M shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$34.8B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Axon Enterprise reported revenue of $904M, +35.3% on Q2 FY2025, and net income of $29M (−18.5%). Operating margin was 5.2%. Free cash flow, operating cash flow less capital expenditures, was −$972K ($20M less $21M). Diluted earnings per share were $0.36.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 6, 2026.

Revenue and net incomeRevenueNet income
−$250M$0$250M$500M$750M$1.0BQ3'22, Revenue: $312MQ3'22, Net income: $12MQ3'22Q4'22, Revenue: $333MQ4'22, Net income: $29MQ4'22Q1'23, Revenue: $344MQ1'23, Net income: $46MQ1'23Q2'23, Revenue: $373MQ2'23, Net income: $12MQ2'23Q3'23, Revenue: $413MQ3'23, Net income: $61MQ3'23Q4'23, Revenue: $430MQ4'23, Net income: $57MQ4'23Q1'24, Revenue: $460MQ1'24, Net income: $133MQ1'24Q2'24, Revenue: $503MQ2'24, Net income: $41MQ2'24Q3'24, Revenue: $544MQ3'24, Net income: $67MQ3'24Q4'24, Revenue: $575MQ4'24, Net income: $135MQ4'24Q1'25, Revenue: $604MQ1'25, Net income: $88MQ1'25Q2'25, Revenue: $669MQ2'25, Net income: $36MQ2'25Q3'25, Revenue: $711MQ3'25, Net income: −$2MQ3'25Q4'25, Revenue: $797MQ4'25, Net income: $3MQ4'25Q1'26, Revenue: $807MQ1'26, Net income: $169MQ1'26Q2'26, Revenue: $904MQ2'26, Net income: $29MQ2'26−$250M$0$250M$500M$750M$1.0BQ3'22, Revenue: $312MQ3'22, Net income: $12MQ4'22, Revenue: $333MQ4'22, Net income: $29MQ4'22Q1'23, Revenue: $344MQ1'23, Net income: $46MQ2'23, Revenue: $373MQ2'23, Net income: $12MQ2'23Q3'23, Revenue: $413MQ3'23, Net income: $61MQ4'23, Revenue: $430MQ4'23, Net income: $57MQ4'23Q1'24, Revenue: $460MQ1'24, Net income: $133MQ2'24, Revenue: $503MQ2'24, Net income: $41MQ2'24Q3'24, Revenue: $544MQ3'24, Net income: $67MQ4'24, Revenue: $575MQ4'24, Net income: $135MQ4'24Q1'25, Revenue: $604MQ1'25, Net income: $88MQ2'25, Revenue: $669MQ2'25, Net income: $36MQ2'25Q3'25, Revenue: $711MQ3'25, Net income: −$2MQ4'25, Revenue: $797MQ4'25, Net income: $3MQ4'25Q1'26, Revenue: $807MQ1'26, Net income: $169MQ2'26, Revenue: $904MQ2'26, Net income: $29MQ2'26

Net income losses drawn in red.

Free cash flow
−$200M−$100M$0$100M$200M$300MQ3'22, Free cash flow: $27MQ3'22Q4'22, Free cash flow: $120MQ4'22Q1'23, Free cash flow: −$65MQ1'23Q2'23, Free cash flow: $30MQ2'23Q3'23, Free cash flow: $49MQ3'23Q4'23, Free cash flow: $116MQ4'23Q1'24, Free cash flow: −$32MQ1'24Q2'24, Free cash flow: $71MQ2'24Q3'24, Free cash flow: $65MQ3'24Q4'24, Free cash flow: $225MQ4'24Q1'25, Free cash flow: $932KQ1'25Q2'25, Free cash flow: −$115MQ2'25Q3'25, Free cash flow: $33MQ3'25Q4'25, Free cash flow: $155MQ4'25Q1'26, Free cash flow: −$55MQ1'26Q2'26, Free cash flow: −$972KQ2'26−$200M−$100M$0$100M$200M$300MQ3'22, Free cash flow: $27MQ4'22, Free cash flow: $120MQ4'22Q1'23, Free cash flow: −$65MQ2'23, Free cash flow: $30MQ2'23Q3'23, Free cash flow: $49MQ4'23, Free cash flow: $116MQ4'23Q1'24, Free cash flow: −$32MQ2'24, Free cash flow: $71MQ2'24Q3'24, Free cash flow: $65MQ4'24, Free cash flow: $225MQ4'24Q1'25, Free cash flow: $932KQ2'25, Free cash flow: −$115MQ2'25Q3'25, Free cash flow: $33MQ4'25, Free cash flow: $155MQ4'25Q1'26, Free cash flow: −$55MQ2'26, Free cash flow: −$972KQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5B$2.0BQ3'22, Cash and equivalents: $148MQ3'22Q4'22, Cash and equivalents: $354MQ4'22Q1'23, Cash and equivalents: $263MQ1'23Q2'23, Cash and equivalents: $474MQ2'23Q3'23, Cash and equivalents: $406MQ3'23Q4'23, Cash and equivalents: $599MQ4'23, Long-term debt: $677MQ4'23Q1'24, Cash and equivalents: $404MQ1'24Q2'24, Cash and equivalents: $566MQ2'24Q3'24, Cash and equivalents: $695MQ3'24Q4'24, Cash and equivalents: $455MQ4'24, Long-term debt: $0Q4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $1.7BQ1'25Q2'25, Cash and equivalents: $615MQ2'25, Long-term debt: $1.7BQ2'25Q3'25, Cash and equivalents: $1.4BQ3'25, Long-term debt: $1.7BQ3'25Q4'25, Cash and equivalents: $1.2BQ4'25, Long-term debt: $1.7BQ4'25Q1'26, Cash and equivalents: $459MQ1'26, Long-term debt: $1.7BQ1'26Q2'26, Cash and equivalents: $598MQ2'26, Long-term debt: $1.7BQ2'26$0$500M$1.0B$1.5B$2.0BQ3'22, Cash and equivalents: $148MQ4'22, Cash and equivalents: $354MQ4'22Q1'23, Cash and equivalents: $263MQ2'23, Cash and equivalents: $474MQ2'23Q3'23, Cash and equivalents: $406MQ4'23, Cash and equivalents: $599MQ4'23, Long-term debt: $677MQ4'23Q1'24, Cash and equivalents: $404MQ2'24, Cash and equivalents: $566MQ2'24Q3'24, Cash and equivalents: $695MQ4'24, Cash and equivalents: $455MQ4'24, Long-term debt: $0Q4'24Q1'25, Cash and equivalents: $1.1BQ1'25, Long-term debt: $1.7BQ2'25, Cash and equivalents: $615MQ2'25, Long-term debt: $1.7BQ2'25Q3'25, Cash and equivalents: $1.4BQ3'25, Long-term debt: $1.7BQ4'25, Cash and equivalents: $1.2BQ4'25, Long-term debt: $1.7BQ4'25Q1'26, Cash and equivalents: $459MQ1'26, Long-term debt: $1.7BQ2'26, Cash and equivalents: $598MQ2'26, Long-term debt: $1.7BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

Axon Enterprise income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 28, 2025Q3 FY2024ended Sep 30, 2024filed Nov 8, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue904807797711669604575544+35.3%
Cost of revenue358330335283265238229214+35.2%
Gross profit546477461427404366346331+35.3%
Research and development209189194177163151135114+28.4%
Selling, general and administrative291259317253242224227192+20.1%
Operating income4729(50)(2)(1)(9)(16)24+4615.3%
Other income (expense)7189(5)23(32)1149545+122.2%
Pretax income33200(66)16(39)1088580+184.1%
Income tax331(69)18(75)20(51)13+104.3%
Net income291693(2)368813567−18.5%
Diluted EPS ($)0.362.05—(0.03)0.441.08—0.86−18.2%
Diluted shares (millions)8382—788281—78—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

Axon Enterprise balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 28, 2025Q3 FY2024ended Sep 30, 2024filed Nov 8, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents5984591,2011,4246151,093455695−2.9%
Short-term investments762605059531,4711,099333312−94.9%
Total current assets3,0052,7443,7134,2173,8283,7772,2972,434−21.5%
Total assets7,4817,0677,0006,6576,2156,0834,4754,006+20.4%
Total current liabilities1,3981,2081,4701,3501,2971,3371,6781,503+7.8%
Long-term debt1,7321,7311,7301,7291,7291,7280—+0.2%
Total liabilities3,8073,5333,7583,6303,4833,5272,1471,906+9.3%
Stockholders’ equity3,6753,5343,2433,0282,7322,5562,3282,100+34.5%
Shares outstanding (millions)8181807979787776—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

Axon Enterprise cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 28, 2025Q3 FY2024ended Sep 30, 2024filed Nov 8, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow20(32)21760(92)2625091+121.9%
Capital expenditures2123622723252526−8.3%
Free cash flow (CFO − capex)(1)(55)15533(115)122565+99.2%
Depreciation and amortization3230272017191813+89.2%
Share repurchases—————————
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 25, 2026.

Income statement

Axon Enterprise income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 28, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 28, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 6, 2017FY2015ended Dec 31, 2015filed Mar 7, 2016FY2014ended Dec 31, 2014filed Mar 12, 2015FY2013ended Dec 31, 2013filed Mar 10, 2014FY2012ended Dec 31, 2012filed Mar 8, 2013FY2011ended Dec 31, 2011filed Mar 13, 2012FY2010ended Dec 31, 2010filed Aug 8, 2011FY2009ended Dec 31, 2009filed Aug 8, 2011
Revenue2,7802,0831,5611,1878666815314203442681981651381159087—
Cost of revenue1,121841605461320265224161137986963524742——
Gross profit1,6581,2419557265464163072592071711291028668454563
Research and development6844423042341941231017755312415108101120
Selling, general and administrative1,03674149539951530721315713910870544739383943
Operating income(62)5915793(163)(14)(6)25133235332823(11)(5)0
Other income (expense)100286(42)9925————————————
Pretax income19382157196(136)(6)228163135322823(10)(5)0
Income tax(106)4(19)49(80)(5)1(1)11141512108(3)(1)0
Net income125377176147(56)(2)12951720201815(7)(4)0
Diluted EPS ($)1.514.802.332.03(0.91)(0.03)0.010.500.100.320.360.370.340.27(0.12)(0.07)0.00
Diluted shares (millions)8279757366626058545455555455596362

Balance sheet

Axon Enterprise balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 28, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 28, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 6, 2017FY2015ended Dec 31, 2015filed Mar 7, 2016FY2014ended Dec 31, 2014filed Mar 12, 2015FY2013ended Dec 31, 2013filed Mar 10, 2014FY2012ended Dec 31, 2012filed Mar 8, 2013FY2011ended Dec 31, 2011filed Mar 13, 2012FY2010ended Dec 31, 2010filed Aug 8, 2011FY2009ended Dec 31, 2009filed Aug 8, 2011
Cash and equivalents1,201455599354356155172349754160484236214346
Short-term investments50533364458215407179074850339250—
Total current assets3,7132,2972,3941,8051,10998260955811417716113597796282—
Total assets7,0004,4753,4092,8521,6881,381846732169278230185148116105136—
Total current liabilities1,4701,6787626034192561961689778383223181612—
Long-term debt1,7300677——————————————
Total liabilities3,7582,1471,7931,583640405302265153127735640292319—
Stockholders’ equity3,2432,3281,6161,2711,0509765434671421511571291088782118118
Shares outstanding (millions)807775737164605953525453525365——

Cash flow statement

Axon Enterprise cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 28, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 28, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 6, 2017FY2015ended Dec 31, 2015filed Mar 7, 2016FY2014ended Dec 31, 2014filed Mar 12, 2015FY2013ended Dec 31, 2013filed Mar 10, 2014FY2012ended Dec 31, 2012filed Mar 8, 2013FY2011ended Dec 31, 2011filed Mar 13, 2012FY2010ended Dec 31, 2010filed Aug 8, 2011FY2009ended Dec 31, 2009filed Aug 8, 2011
Operating cash flow21140818923512438666418214635322717110
Capital expenditures1367960565073161110563212414
Free cash flow (CFO − capex)7533013018075(34)50538164033312515(3)(4)
Depreciation and amortization8348192319121111843457874
Share repurchases———————0034822252032——
Dividends paid—————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$27M
95 sales by 4 insiders; officers and directors $27M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$130M
281 sales by 11 insiders; officers and directors $130M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Brooks CameronCHIEF REVENUE OFFICERtax withholding5,850$422.21$2M61,396Oct 2, 2026
Sep 11, 2026Fields IsaiahChief Legal Officeropen-market sale10b5-11,017$480.45$489K56,264Sep 14, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-171$501.99$36K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-1410$503.74$207K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-11,104$505.59$558K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-1744$506.48$377K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-1749$507.48$380K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-11,774$508.45$902K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-11,319$509.32$672K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-11,348$510.59$688K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-11,251$511.43$640K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-11,033$512.70$530K3MSep 10, 2026
Sep 8, 2026Smith Patrick WCHIEF EXECUTIVE OFFICER, Directoropen-market sale10b5-1197$513.38$101K3MSep 10, 2026
Aug 31, 2026Mak Jennifer HChief Accounting Officertax withholding156$566.56$88K13,600Sep 2, 2026
Aug 31, 2026Brooks CameronCHIEF REVENUE OFFICERtax withholding735$566.56$416K67,246Sep 2, 2026
Aug 31, 2026Coughlin Elizabeth ReidChief Human Officertax withholding479$566.56$272K40,363Sep 2, 2026
Aug 31, 2026Fields IsaiahChief Legal Officertax withholding763$566.56$432K57,281Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-1347$561.08$195K313,402Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-1373$562.27$210K313,029Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-1359$563.50$202K312,670Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-11,232$564.47$695K311,438Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-1661$565.37$374K310,777Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-1188$566.32$106K310,589Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-1193$567.53$110K310,396Sep 2, 2026
Aug 31, 2026Isner JoshuaPRESIDENTopen-market sale10b5-11,684$568.95$958K308,712Sep 2, 2026

Full insider history for Axon Enterprise, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held AXON in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded AXON by quarter.

FundManagerQuarterValueSharesWeightMove
Baron Capital GroupRon BaronQ2 2026$86M153,6150.13%added +30.2%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
AXON ENTERPRISE, INC., CIK 1069183 on EDGAR
Extract generated
October 6, 2026
Withheld
3 line-years whose four quarters do not sum to the filed year: capex FY2011, depreciation amortization FY2011, capex FY2012
Repaired
4 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: net income FY2017, pretax income FY2019, operating income FY2020, income tax FY2024
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated October 6, 2026.

JSON file
/data/financials/AXON.json